Stocks · News reference
Quoin Pharmaceuticals Announced Interim Analysis Of First Six Patients To Complete 12 Weeks Of Treatment Met Pre-Specified Alpha Adjusted Target For Primary Endpoint With Statistical Significance
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Quoin Pharmaceuticals, Ltd. (QNRX)
Filed: 2026-08-28 AccNo: 0001104659-26-102917 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Dow Gains 100 Points; Chicago PMI Falls In August
US stocks up, Dow gains 100 points, S&P 500 and NASDAQ also rise. Communication services up 1.1%, technology down 0.3%. Chicago Business Barometer dips.
Quoin Pharmaceuticals Stock Surges Friday: What's Happening?
Shares of Quoin Pharmaceuticals are rallying Friday after pre-market updates on positive trial results and a major institutional financing.